Table 3. Frequency of HFE genotype in our previous study, TCGA GBM (TP, NB) samples1.
| PSHCI GBM (n = 97)3 | TP (n = 264) | NB (n = 261) | |
|---|---|---|---|
| H63D/+ | 18 (18.6%) | 61 (23.1%) | 60 (23.0%) |
| H63D/H63D | 1 (1.0%) | 6 (2.3%) | 6 (2.3%) |
| C282Y/+ | 6 (6.2%) | 15 (5.7%) | 16 (6.1%) |
| C282Y/C282Y | 0 (0.0%) | 2 (0.8%) | 1 (0.4%) |
| H63D/C282Y | 0 (0.0%) | 3 (1.1%) | 3 (1.1%) |
| +/+ 2 | 72 (74.2%) | 177 (67.0%) | 175 (67.0%) |
| Total | 97 | 264 | 261 |
1 The studied samples of PSHCI and TCGA GBM patients were all Caucasians
2 +/+: no mutation at 63 and 282 amino acids of HFE gene
3 Lee SY, et al. J Neurooncol. 2015;122:97–104.